Search Results - "Agnès, Fournier"

Refine Results
  1. 1

    Design of a generic model based on physiology for persistent organic pollutants in laying hens: Applications on chlordecone and chlorinated paraffins by Joachim, Thiébaut, Cyril, Feidt, Ronan, Cariou, Gaud, Dervilly, Agnès, Fournier

    Published in The Science of the total environment (20-03-2024)
    “…A Physiology Based Pharmacokinetic (PBPK) model has been developed to predict the kinetics of Persistent Organic Pollutants (POPs) in laying hens. Different…”
    Get full text
    Journal Article
  2. 2

    Use of menopausal hormone therapy and ovarian cancer risk in a French cohort study by Fournier, Agnès, Cairat, Manon, Severi, Gianluca, Gunter, Marc J, Rinaldi, Sabina, Dossus, Laure

    “…Abstract Background Epidemiological studies have found that menopausal hormone therapy (MHT) use is associated with an increased ovarian cancer risk. However,…”
    Get full text
    Journal Article
  3. 3

    Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study by Fournier, Agnès, Berrino, Franco, Clavel-Chapelon, Françoise

    Published in Breast cancer research and treatment (01-01-2008)
    “…Large numbers of hormone replacement therapies (HRTs) are available for the treatment of menopausal symptoms. It is still unclear whether some are more…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Association of Physical Activity and Parkinson Disease in Women: Long-term Follow-up of the E3N Cohort Study by Portugal, Berta, Artaud, Fanny, Degaey, Isabelle, Roze, Emmanuel, Fournier, Agnès, Severi, Gianluca, Canonico, Marianne, Proust-Lima, Cécile, Elbaz, Alexis

    Published in Neurology (25-07-2023)
    “…Previous cohort studies reported that a single measure of physical activity (PA) assessed at baseline was associated with lower Parkinson disease (PD)…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Organochlorine POPs sequestration strategy by carbonaceous amendments of contaminated soils: Toward a better understanding of the transfer reduction to laying hens by El Wanny, Nadine, Le Roux, Yves, Fournier, Agnès, Baroudi, Moomen, Woignier, Thierry, Feidt, Cyril, Delannoy, Matthieu

    Published in Journal of hazardous materials (15-07-2022)
    “…PCBs, PCDD/Fs, and Chlordecone (CLD) are POPs found in soils and transferred to animals through involuntary soil ingestion. In this frame, the amendment of…”
    Get full text
    Journal Article
  8. 8

    Antiplatelet drugs and breast cancer risk in a large nationwide Danish case-control study by Cairat, Manon, Pottegård, Anton, Olesen, Morten, Dossus, Laure, Fournier, Agnès, Hicks, Blánaid

    Published in International journal of cancer (01-04-2023)
    “…Low-dose aspirin has been hypothesized to prevent cancer risk by inhibiting platelet aggregation. However, the anti-cancer effect of low-dose aspirin has…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Associations Between Migraine and Type 2 Diabetes in Women: Findings From the E3N Cohort Study by Fagherazzi, Guy, El Fatouhi, Douae, Fournier, Agnès, Gusto, Gaelle, Mancini, Francesca Romana, Balkau, Beverley, Boutron-Ruault, Marie-Christine, Kurth, Tobias, Bonnet, Fabrice

    Published in JAMA neurology (01-03-2019)
    “…Little is known about the associations between migraine and type 2 diabetes and the temporality of the association between these 2 diseases. To evaluate the…”
    Get more information
    Journal Article
  11. 11

    Use of nonsteroidal anti-inflammatory drugs and breast cancer risk in a prospective cohort of postmenopausal women by Cairat, Manon, Al Rahmoun, Marie, Gunter, Marc J, Severi, Gianluca, Dossus, Laure, Fournier, Agnès

    Published in Breast cancer research : BCR (31-10-2020)
    “…Although anti-inflammatory agents could theoretically have anticancer properties, results from cohort studies on nonsteroidal anti-inflammatory drugs (NSAIDs)…”
    Get full text
    Journal Article
  12. 12

    Reproductive characteristics, use of exogenous hormones and Parkinson disease in women from the E3N study by Pesce, Giancarlo, Artaud, Fanny, Roze, Emmanuel, Degaey, Isabelle, Portugal, Berta, Nguyen, Thi Thu Ha, Fournier, Agnès, Boutron-Ruault, Marie-Christine, Severi, Gianluca, Elbaz, Alexis, Canonico, Marianne

    Published in Brain (London, England : 1878) (01-06-2023)
    “…Abstract Despite experimental studies suggesting a disease-modifying role of oestrogens, results from epidemiological studies on the relation of reproductive…”
    Get full text
    Journal Article
  13. 13

    The mode of action of different organochlorine pesticides families in mammalians by Baratzhanova, Gulminyam, Fournier, Agnès, Delannoy, Matthieu, Baubekova, Almagul, Altynova, Nazym, Djansugurova, Leyla, Cakir-Kiefer, Céline

    Published in Environmental toxicology and pharmacology (01-09-2024)
    “…Organochlorine pesticides (OCPs) show differences in their chemical structure, mechanism of toxicity, and target organisms. However, OCPs also have some common…”
    Get full text
    Journal Article
  14. 14

    Educational level and characteristics of invasive breast cancer: findings from a French prospective cohort by Berger, Eloïse, Gelot, Amandine, Fournier, Agnès, Dossus, Laure, Boutron-Ruault, Marie-Christine, Severi, Gianluca, Castagné, Raphaële, Delpierre, Cyrille

    Published in Cancer causes & control (01-08-2024)
    “…Purpose Breast cancer (BC) characteristics are known to influence patients survival. Social differences have been reported by previous studies for those…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Estimate of deaths due to valvular insufficiency attributable to the use of benfluorex in France by Fournier, Agnès, Zureik, Mahmoud

    Published in Pharmacoepidemiology and drug safety (01-04-2012)
    “…ABSTRACT Purpose To estimate the number of deaths from valvular insufficiency caused by the use of the fenfluramine‐derivative benfluorex during the period…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Risk of breast cancer after stopping menopausal hormone therapy in the E3N cohort by Fournier, Agnès, Mesrine, Sylvie, Dossus, Laure, Boutron-Ruault, Marie-Christine, Clavel-Chapelon, Françoise, Chabbert-Buffet, Nathalie

    Published in Breast cancer research and treatment (01-06-2014)
    “…Questions remain on how the excess risk of breast cancer associated with menopausal hormone therapy (MHT) evolves after treatment stops. We investigated that…”
    Get full text
    Journal Article
  19. 19

    Use of Different Postmenopausal Hormone Therapies and Risk of Histology- and Hormone Receptor–Defined Invasive Breast Cancer by FOURNIER, Agnès, FABRE, Alban, MESRINE, Sylvie, BOUTRON-RUAULT, Marie-Christine, BERRINO, Franco, CLAVEL-CHAPELON, Francoise

    Published in Journal of clinical oncology (10-03-2008)
    “…We previously found that the risk of invasive breast cancer varied according to the progestagen component of combined postmenopausal hormone therapy (CHT):…”
    Get full text
    Journal Article
  20. 20

    Estrogen-Progestagen Menopausal Hormone Therapy and Breast Cancer: Does Delay From Menopause Onset to Treatment Initiation Influence Risks? by FOURNIER, Agnes, MESRINE, Sylvie, BOUTRON-RUAULT, Marie-Christine, CLAVEL-CHAPELON, Françoise

    Published in Journal of clinical oncology (01-11-2009)
    “…To investigate whether the relation between estrogen-progestagen menopausal hormone therapy (EP-MHT) and breast cancer risk varies according to the delay…”
    Get full text
    Journal Article